Digital health company that harnesses gut microbiome & genetic risk signals to reverse inflammatory digestive disorders, diabetes, obesity.
We are on a mission to empower every individual with critical knowledge about their genetics and gut microbiome and deliver convenient, personalized, and connected care so that they can live disease-free. We are the first company to partner with employers and health plans to provide tailored whole-person treatment plans and care to people struggling with digestive, GI, and associated obesity and cardiometabolic illnesses. We diagnose genetics, gut microbiome, food, lifestyle, and clinical signals to target the root cause of disease.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 20, 2020 | Series A | $5.40M | 1 | — | — | Detail |
Mar 18, 2020 | Convertable Note | $800K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Wisdom LLP | — | Series A |